COVID-19 Early Treatment Fund & WUSM St. Louis Pursue Fluvoxamine as Early Stage Treatment for COVID-19: Positive Momentum

COVID-19 Early Treatment Fund & WUSM St. Louis Pursue Fluvoxamine as Early Stage Treatment for COVID-19 Positive Momentum

Washington University School of Medicine in St. Louis (WUSM St. Louis) investigators are now preparing for a critically important Phase 3 clinical trial to test a medicine for patients with mild symptoms in the early course of COVID-19 treatment. Called the “STOP COVID Trial 2,” this “contactless” or remote study means that volunteers may participate without leaving their home. The investigational team supplies the medication, known as fluvoxamine, delivered via courier, or shipped overnight. The fundamental study question: does fluvoxamine help to stop the worsening of symptoms associated with COVID-19, hence preventing hospitalization? This is a timely research program. The first trial in this program, the “Stop COVID-Trial,” showed positive results. So much so that the program’s sponsor, a wealthy entrepreneur, and philanthropist named Steve Kirsch, founder of the COVID-19 Early Treatment Fund (CETF), continues to invest in critically important research investigating the efficacy early course COVID-19 FDA approved repurposed treatments, such as fluvoxamine. Mr. Kirsch, founder of several successful companies, is doing the nation and the world a favor by putting lots of his own ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee